哈药集团股份有限公司 is a large enterprise group that integrates pharmaceutical manufacturing, trade, and research.

哈药集团股份有限公司

哈药集团有限公司 | 33 followers on LinkedIn. 

工程师 at 哈药

周宇光 zhouyuguang

哈药 - 淘宝

王梦琴

哈药 - 上尉

陈兆伟

哈药 — 销售经理

高鹏

哈药集团有限公司

Harbin Pharmaceutical Group Co., Ltd. engages in the research, development, manufacture, and trade of pharmaceuticals in China and internationally. The company operates through seven segments: Antibiotics, Small-Molecular Drug Preparations, OTC and Healthcare Products, Modern Chinese Medicines, Biopharmaceuticals, Animal Vaccines, and Medicine Circulations. It offers a series of penicillin and cephalosporin products, as well as intermediates. The company's lead products include Shuang Huanglian freeze-dried injection; Danshen freeze-dried injection; Shuang Huanglian powder for injection; roxithromycin dispersible tablets; belladonna, sulfamethoxazole, and trimerhoprim tablets; pediatric paracetamol, atificial cow-bezoar, and chlorphenamine maleate granules; Shuanghuanglian oral liquid; and ceftriaxone sodium for injection. Its lead products also comprise amoxicillin capsules, cefotiam hydrochloride for injection, panax ginseng extract, cefepime hydrochloride for injection, cefoperazone sodium for injection, and amoxicillin sodium and clavulanate potassium for injection; cefuroxime sodium, ceftazidime, cefotaxime sodium, and ceftriaxone sodium for injections; and ampicillin capsules. In addition, the company offers medical protective and disposable surgical masks, medical disposable protective gowns, and isolation gowns. It offers its products under the Hongyan Yaopin, Guangwei, Renmin Tongtai, Hayao Shengwu, Baohulu, Manshanhong, Hutong, Hayaoliu, Gaizhonggai, Sanchine, Shiyitang, and Hayao brands. The company is based in Harbin, China.

Harbin Pharmaceutical Group Co., Ltd.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 5, 2024 7:03 PM	4a4d64e3
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 5, 2024 7:03 PM	9be97a72
crunchbase trigger	general	Nov 5, 2024 7:03 PM	7bc12879
crunchbase profile	general
li profile	general	Nov 5, 2024 7:03 PM	52803238
translate crunchbase fundingrounds	general
peers	general	Nov 5, 2024 7:03 PM	f99815ce
news basic	general	Nov 5, 2024 7:03 PM	ee1b2c74
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

6006

COM:HAYAO

哈药集团股份有限公司

Last Close

3.86

22/11 07:00

Market Cap

7.48B

Beta: -

Volume Today

42.73M

Avg: -